Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of hereditary amyotrophic lateral sclerosis.
Rev Neurol (Paris). 2023 Jan-Feb;179(1-2):54-60. doi: 10.1016/j.neurol.2022.09.001. Epub 2022 Nov 3.
Rev Neurol (Paris). 2023.
PMID: 36336493
Review.
Currently, only four molecules can be prescribed for amyotrophic lateral sclerosis (ALS), of which only one is approved worldwide for this indication, riluzole. Although progress in the therapeutic field remains unsatisfactory, we have to notice that genetics have undergon …
Currently, only four molecules can be prescribed for amyotrophic lateral sclerosis (ALS), of which only one is approved worldwide for this i …
Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years.
Wixner J, Suhr OB, Anan I.
Wixner J, et al.
Expert Rev Gastroenterol Hepatol. 2018 Jan;12(1):73-81. doi: 10.1080/17474124.2018.1397511. Epub 2017 Nov 20.
Expert Rev Gastroenterol Hepatol. 2018.
PMID: 29073801
Item in Clipboard
Cite
Cite